Amoxi-Tabs C®-250

Amoxi-Tabs C®-250

Broad-spectrum antibiotic with bacterial resistance inhibitor

Canines Tablet Oral

Amoxicillin base 200 mg, clavulanic acid 50 mg; excipients q.s. ad 1 tablet.

For the treatment of periodontal infections caused by susceptible strains (aerobic and anaerobic bacterias). Treatment of skin and soft tissues infections caused by susceptible species of Staphylococcus spp. E. coli, Pasteurella spp. and Streptococcus spp. Treatment of respiratory tract and urinary tract infections, including those caused by susceptible species of E. coli. Osteomyelitis treatment and other bacterial complications susceptible to amoxicillin.

1 tablet/16 kg every 8 - 12 hours for at least 3 days. Administer through oral route.
Box x 10 tablets ,

Registro SAGARPA: México Registro SAGARPA Q-0616-030

Petmedica® is a division of Agrovet Market S.A.
This content is an informational reference and should not be considered as recommendation of use.

You may also be interested

Amoxi-Tabs C®-250
Broad-spectrum antibiotic with bacterial resistance...
Antibiotic-antiinflammatory combination
Liver protector
Supplements Injectables
Contact Us
Comprar Ahora